Cargando…
CD40-activated B cells induce anti-tumor immunity in vivo
The introduction of checkpoint inhibitors represents a major advance in cancer immunotherapy. Some studies on checkpoint inhibition demonstrate that combinatorial immunotherapies with secondary drivers of anti-tumor immunity provide beneficial effects for patients that do not show a strong endogenou...
Autores principales: | Wennhold, Kerstin, Weber, Tanja M., Klein-Gonzalez, Nela, Thelen, Martin, Garcia-Marquez, Maria, Chakupurakal, Geothy, Fiedler, Anne, Schlösser, Hans A., Fischer, Rieke, Theurich, Sebastian, Shimabukuro-Vornhagen, Alexander, von Bergwelt-Baildon, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438605/ https://www.ncbi.nlm.nih.gov/pubmed/26934557 http://dx.doi.org/10.18632/oncotarget.7720 |
Ejemplares similares
-
Pretransplant Comorbidities Maintain Their Impact on Allogeneic Stem Cell Transplantation Outcome 5 Years Posttransplant: A Retrospective Study in a Single German Institution
por: Chemnitz, Jens M., et al.
Publicado: (2014) -
Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma
por: Lechner, Axel, et al.
Publicado: (2017) -
The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2012) -
Characterization of tumor-associated B-cell subsets in patients with colorectal cancer
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2014) -
Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma
por: Lechner, Axel, et al.
Publicado: (2019)